Dr. Eric Berg DC · 2026-08-28 · Eric Berg (host), Steve, Sura, Maria, Noelle
The Dr. Berg Show LIVE - August 28, 2026
28 research-tied claims examined: 4 contradicted 7 overstated 2 context 11 supported 4 unverified
7 Overstated
St. John's wort has been shown to significantly improve both depression and anxiety.
"typically, yeah, St. John's wort has been shown to greatly improve not just depression but anxiety." (said at 0:05:33)
Extensive meta-analytic evidence supports the efficacy of St. John's wort (Hypericum perforatum) for mild-to-moderate depression, demonstrating symptom reductions comparable to standard selective serotonin reuptake inhibitors (SSRIs). However, systematic reviews and clinical guidelines evaluate the evidence for St. John's wort as a treatment for primary anxiety or anxiety disorders as insufficient and do not recommend it as an anxiolytic. Claiming that it has been shown to greatly improve anxiety alongside depression overstates the available clinical evidence.
- contradicts: Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic r… (Nutrition journal 2010) · cited 179x in the literature
"St. John's wort monotherapy has insufficient evidence for use as an effective anxiolytic treatment." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Clinical use of Hypericum perforatum (St John's wort) in depression: A meta-analysis. (Journal of affective disorders 2017) · cited 319x in the literature
"In patients with depression, St John's wort demonstrated comparable response (pooled RR 0.983, 95% CI 0.924-1.042, p<0.001) and remission (pooled RR 1.013, 95% CI 0.892-1.134, p<0.001) rate, and significantly lower discontinuation/dropout (pooled OR 0.587, 95% CI 0.478-0.697, p<0.001) rate compared to standard SSRIs. The pooled SMD from baseline HAM-D scores (pooled SMD -0.068, 95% CI -0.127 to 0.021, p<0.001) also support its significant clinical efficacy in ameliorating depressive symptoms." (abstract, results, passage verified)
pubmedfull study (doi) - context: Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and ph… (The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2022) · cited 205x in the literature
"Phytoceuticals with supporting Grade A evidence and positive directionality included St John's wort (+++), saffron (++), curcumin (++), and lavender (+) in the treatment of unipolar depression, while rhodiola use was not supported for use in mood disorders. Ashwagandha (++), galphimia (+), and lavender (++) were modestly supported in the treatment of anxiety disorders" (abstract, results, passage verified)
pubmedfull study (doi)
Approximately 80% of the human population is colonized with Helicobacter pylori.
"80% of the population has this microbe and it normally is not bothering us." (said at 0:17:26)
Global systematic reviews and meta-analyses establish that approximately 43% to 50% of the world's population is colonized or infected with Helicobacter pylori, not 80%. While prevalence varies markedly by region and reaches 70% or higher in certain developing regions (such as parts of Africa), the worldwide average is substantially lower than 80% and has steadily declined over recent decades.
Estrogen protects skeletal muscle tissue from being lost in women.
"What happens during perimenopause is you have this drop of estrogen. Estrogen is the thing that protects the the muscle uh from being lost." (said at 0:19:31)
While estradiol plays a biological role in muscle metabolism—acting via estrogen receptors to regulate mitochondrial function, satellite cell activity, and muscle protein turnover—attributing muscle mass preservation primarily to estrogen overstates its role. Observational and longitudinal studies (such as the ERMA cohort) demonstrate that the menopausal transition and declining estradiol are associated with decreases in lean and muscle mass. However, a 2019 systematic review and meta-analysis of 12 randomized controlled trials (4,474 postmenopausal women) found that hormone therapy did not produce a statistically significant preservation of lean body mass compared to controls (difference of 0.06 kg, 95% CI -0.05 to 0.18 kg). Mechanical loading via resistance training and adequate dietary protein remain the primary protective drivers of skeletal muscle maintenance.
- contradicts: Association Between Hormone Therapy and Muscle Mass in Postmenopausal Women: A Systematic … (JAMA network open 2019) · cited 106x in the literature
"Overall, HT users lost 0.06 kg (95% CI, -0.05 to 0.18) less LBM compared with control participants, but the difference was not statistically significant (P = .26)... This systematic review and meta-analysis did not show a significant beneficial or detrimental association of HT with muscle mass." (abstract, results and conclusions)
pubmedfull study (doi) - supports: Role of Menopausal Transition and Physical Activity in Loss of Lean and Muscle Mass: A Fol… (Journal of clinical medicine 2020) · cited 106x in the literature
"Significant decreases were seen in lean body mass (LBM), lean body mass index (LBMI), appendicular lean mass (ALM), appendicular lean mass index (ALMI), leg lean mass and thigh muscle cross-sectional area (CSA). Menopausal status was a significant predictor for all tested muscle mass variables, while physical activity was an additional significant contributor" (abstract, results, passage verified)
pubmedfull study (doi) - context: Menopause, Female Sex Hormones, Skeletal Muscle Mass and Muscle Protein Turnover in Humans… (Journal of cachexia, sarcopenia and muscle 2026) · cited 7x in the literature
"Longitudinal (n = 4/5) and cross-sectional (n = 7/11) studies demonstrate a reduction in lean or muscle mass across the menopausal transition with -2.5% and -5.7% reductions in perimenopausal and postmenopausal women, respectively, compared to premenopausal women." (abstract, passage verified)
pubmedfull study (doi)
Berberine increases insulin sensitivity, functioning similarly to metformin but with fewer side effects.
"berberine mainly helps, um, make insulin more sensitive. So, it works like metformin in a way. Uh, it has less side effects." (said at 0:32:43)
The claim bundles two assertions. The first assertion—that berberine improves insulin sensitivity and has glucose-lowering effects comparable to metformin—is supported by randomized controlled trials and meta-analyses in type 2 diabetes and polycystic ovary syndrome (PCOS). However, the assertion that berberine has fewer side effects than metformin is overstated. Clinical trials and systematic reviews show that berberine causes a similar profile of adverse effects to metformin, primarily gastrointestinal symptoms such as diarrhea, constipation, nausea, flatulence, and abdominal discomfort (reported in up to ~35% of trial participants). Head-to-head evidence does not reliably demonstrate a clinically meaningful reduction in side effects compared to metformin.
- partial: Efficacy of berberine in patients with type 2 diabetes mellitus. (Metabolism: clinical and experimental 2008) · cited 785x in the literature
"In study A, 36 adults with newly diagnosed type 2 diabetes mellitus were randomly assigned to treatment with berberine or metformin (0.5 g 3 times a day) in a 3-month trial. The hypoglycemic effect of berberine was similar to that of metformin... During the trial, 20 (34.5%) patients experienced transient gastrointestinal adverse effects." (abstract, results, passage verified)
pubmedfull study (doi) - partial: Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysi… (Evidence-based complementary and alternative medicine : eCAM 2012) · cited 222x in the literature
"Compared with oral hypoglycaemics including metformin, glipizide, or rosiglitazone, berberine did not demonstrate a significantly better glycaemic control but showed a mild antidyslipidemic effect... No serious adverse effects from berberine were reported." (abstract, results)
pubmedfull study (doi) - partial: The Effect of Berberine on Reproduction and Metabolism in Women with Polycystic Ovary Synd… (Evidence-based complementary and alternative medicine : eCAM 2019) · cited 36x in the literature
"However, berberine appeared to be more efficacious for improving insulin resistance and dyslipidemia and decreasing androgen levels and LH/FSH ratio in women with PCOS when compared with metformin." (abstract, results, passage verified)
pubmedfull study (doi)
Iodine deficiency in an infant drops IQ by at least 12 points.
"If that infant is deficient in iodine, the IQ drops at least 12 points." (said at 0:53:12)
The claim is overstated. The figure of roughly 12 to 13.5 IQ points represents the average population-level deficit observed in severe endemic iodine deficiency (primarily driven by maternal deficiency during fetal neurodevelopment), not a guaranteed floor or minimum ("at least 12 points") for an individual infant. A systematic review and meta-analysis specifically evaluating children aged 5 years and under across randomized and cohort studies found average cognitive deficits ranging from 6.9 to 10.2 IQ points between iodine-deficient and iodine-replete children, depending on study design.
- partial: The effects of iodine on intelligence in children: a meta-analysis of studies conducted in… (Asia Pacific journal of clinical nutrition 2005) · cited 248x in the literature
"The effect size was an increase of 0.83, 0.82, and 0.32 SIQP respectively, for the children living in IS communities compared with those living in ID areas with no iodine supplementation, with inadequate iodine supplementation, or children who had received iodine during their mothers' pregnancy and after birth. These equal to 12.45, 12.3, 4.8 IQ points." (abstract, results, passage verified)
pubmed - partial: Iodine and mental development of children 5 years old and under: a systematic review and m… (Nutrients 2013) · cited 205x in the literature
"Average effect sizes for these four designs were 0.68 (2 RCT studies), 0.46 (8 non-RCT studies), 0.52 (9 cohort stratified by mothers' iodine status), and 0.54 (4 cohort stratified by infants' iodine status). This translates into 6.9 to 10.2 IQ points lower in iodine deficient children compared with iodine replete children." (abstract, results, passage verified)
pubmedfull study (doi)
Weight-bearing resistance training reverses osteoporosis in women.
"They've done uh a research uh study on women with osteoporosis doing weight training like loading the muscles and and they actually reverse osteoporosis." (said at 0:56:45)
High-intensity resistance training (such as the protocol evaluated in the LIFTMOR randomized controlled trial) and dynamic resistance exercise significantly improve bone mineral density (BMD) and avert postmenopausal bone loss. However, claiming it "reverses osteoporosis" is an overstatement of the magnitude of effect: trials and meta-analyses show modest improvements in BMD (typically in the range of ~1% to 3% at the lumbar spine and femoral neck) and bone geometry, which helps mitigate fracture risk and slow or partially improve bone loss, but does not completely restore osteoporotic bone back to normal reference ranges.
- partial: Exercise for preventing and treating osteoporosis in postmenopausal women. (The Cochrane database of systematic reviews 2011) · cited 1082x in the literature
"Our results suggest a relatively small statistically significant, but possibly important, effect of exercise on bone density compared with control groups. Exercise has the potential to be a safe and effective way to avert bone loss in postmenopausal women." (abstract, conclusions, passage verified)
pubmedfull study (doi) - partial: High-Intensity Resistance and Impact Training Improves Bone Mineral Density and Physical F… (Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2018) · cited 445x in the literature
"HiRIT (n = 49) effects were superior to CON (n = 52) for lumbar spine (LS) BMD (2.9 ± 2.8% versus -1.2 ± 2.8%, p < 0.001), femoral neck (FN) BMD (0.3 ± 2.6% versus -1.9 ± 2.6%, p = 0.004), FN cortical thickness (13.6 ± 16.6% versus 6.3 ± 16.6%, p = 0.014)" (abstract, results, passage verified)
pubmedfull study (doi) - partial: Effects of dynamic resistance exercise on bone mineral density in postmenopausal women: a … (Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2020) · cited 138x in the literature
"This systematic review and meta-analysis observed a significant low-moderate effect of dynamic resistance exercise on bone mineral density changes in postmenopausal women." (abstract, conclusions, passage verified)
pubmedfull study (doi)
Evidence shows that supporting mitochondria with cofactors including vitamin B2, vitamin B3, and magnesium is beneficial in Parkinson's disease.
"There's been also evidence to show that supporting the mitochondria with cofactors like like vitamin B2 and vitamin B3 and magnesium are also super helpful in Parkinson's." (said at 0:51:05)
While mitochondrial dysfunction is a recognized pathological feature of Parkinson's disease, claiming that mitochondrial cofactors such as vitamin B2 (riboflavin), vitamin B3 (nicotinamide precursors), and magnesium are 'super helpful' overstates the available clinical evidence. Human evidence for riboflavin rests primarily on small, uncontrolled historical studies (e.g., an open-label cohort of 19 patients combining riboflavin with dietary red meat elimination) and preclinical models, with systematic reviews noting clinical application remains insufficiently defined. For vitamin B3 precursors (such as nicotinamide riboside in metabolic activator combinations), a randomized trial demonstrated modest cognitive changes but failed to show improvements in motor function. Robust, high-certainty clinical trial evidence demonstrating that these cofactors provide substantial clinical benefit in Parkinson's disease is lacking.
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.